Dr Mario Sznol talks to ecancer at ASCO 2013 about long-term follow-up results from an expanded phase I study examining the effects of nivolumab in advanced melanoma. 107 patients were treated with five different doses of nivolumab. All patients had disease that worsened despite prior standard...

Dr Swchwartz gives ecancertv his ASCO 2013 highlights. He covers the latest promising news in melanoma and comments on the potential of immunotherapy and antibodies for treatment of other cancers.

Dr Matthew Ellis talks to ecancer at ASCO 2013 about the affects of The Cancer Genome Atlas on research, treatment and next generation sequencing.